P
Pragma Bio (Formerly VastBiome)
VastBiome partners with scientists conducting clinical trials aimed at elucidating the influence of the microbiome on response to therapy
About Pragma Bio (Formerly VastBiome)
PragmaBio operates at the intersection of genomic sequencing, artificial intelligence, and synthetic biology to address some of the most challenging immunologic disorders. The company focuses on discovering biomarkers and developing novel therapeutics by leveraging advanced technologies. PragmaBio serves clients in the healthcare and pharmaceutical sectors, offering solutions that range from biomarker discovery to therapeutic development. The company generates revenue through partnerships, research collaborations, and licensing agreements. By utilizing patient-derived clinical metadata and biospecimen samples, PragmaBio employs machine learning to predict viable biomarkers and therapeutic candidates. The business model also includes the production of small molecules via cell-free expression and high-throughput immune profiling assays for functional screening.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Employees
- 17
- Open positions
- None listed
- Dealroom signal
- 65.2/100
- Industry
- Health, Dating
- Sub-industry
- BioTechnology
- Sector
- Biotechnology, Core AI, Spinout, Tech for Biotech and Pharma, AI Applications, DT and LS, science-based
- Technology
- Artificial Intelligence, Deep Tech, Machine Learning
- Client focus
- B2B
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Mar 2023 | $10M | $40M | The Venture Collective · Viking Global Investors · Merck Global Health Innovation Fund · CJ Investment | ↗ |
| SEED✓Equity / VC | Dec 2020 | $4.5M | $18M | Merck Global Health Innovation Fund · Viking Global Investors · Timewise Investment | — |
Growth signals
Latest recorded traffic for Pragma Bio (Formerly VastBiome) is 690 monthly website visits, down 37.3% over the last three months. Pragma Bio (Formerly VastBiome)'s team declined 5.6% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Pragma Bio (Formerly VastBiome) in the South San Francisco ecosystem
The Pragma Bio (Formerly VastBiome) office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed5 investors entered at this stage
Texas A&M New Ventures Competition
Plug and Play
Merck Global Health Innovation Fund
Viking Global Investors- TITimewise Investment
Series A2 investors entered at this stage
The Venture Collective
CJ Investment
Other known investors10 additional known investors
TMCx Accelerator
Good AI Capital
Harmonix- IVIaso Ventures
Joyance Partners
Kotaro Tamura
MBC Biolabs
Samuel Lee
StartX- TMTodd Meyerrose
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Pragma Bio (Formerly VastBiome) on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Pragma Bio (Formerly VastBiome)’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









